Hemostatic alterations in splenectomized and non-splenectomized patients with β-thalassemia/hemoglobin E disease

Thrombosis Research

Volumn 120, Issue 6, 2007, Pages 805-810

  Tripatara, Amporn ^a,c   Jetsrisuparb, Arunee ^b   Teeratakulpisarn, Jamaree ^b   Kuaha, Kunnika ^a  

^a Division of Medical Technology

^b Faculty of Medicine

^c KHON KAEN UNIVERSITY   (Thailand)

Author keywords

thalassemia; Coagulation; Fibrinolysis; Hemoglobin E; Splenectomy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; D DIMER; DEFEROXAMINE MESYLATE; FERRITIN; FIBRINOGEN; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR;

ADOLESCENT; ARTICLE; BETA THALASSEMIA; BLOOD CLOTTING; BLOOD TRANSFUSION; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBRINOLYSIS; HEMOGLOBIN E DISEASE; HEMOGLOBINOPATHY; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SPLENECTOMY; THROMBOSIS;

ADOLESCENT; ANEMIA, HEMOLYTIC, CONGENITAL; BETA-THALASSEMIA; BLOOD COAGULATION; CHILD; FEMALE; FIBRINOLYSIS; HEMOGLOBIN E; HEMOGLOBINS; HEMOGLOBINURIA; HEMOSTASIS; HUMANS; MALE; SEVERITY OF ILLNESS INDEX; SPLENECTOMY;

EID: 34548677281     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.02.006     Document Type: Article

References (23)

1. Fucharoen S., Winichagoon P., Siritanaratkul N., Chowthaworn J., and Pootrakul P. Alpha- and beta-thalassemia in Thailand. Ann N Y Acad Sci 850 (1998) 412-414
2. Gillis S., Cappellini M.D., Goldfarb A., Ciceri L., Fiorelli G., and Rachmilewitz E.A. Pulmonary thromboembolism in thalassemia intermedia patients. Hematologica 84 (1999) 957-958
3. Sonakul D., Pacharee P., Laohapand T., Fucharoen S., and Wasi P. Pulmonary artery obstruction in thalassemia. Southeast Asian J Trop Med Public Health 11 (1980) 516-523
4. Sumiyoshi A., Thakerngpol K., and Sonakul D. Pulmonary microthromboemboli in thalassemic cases. Southeast Asian J Trop Med Public Health 23 (1992) 29-31
5. Fucharoen S., Winichchagoon P., Siritanaratkul N., Sonakul D., Chantaraksri U., Bunyaratvej A., et al. Hypoxia in thalassemia. Southeast Asian J Trop Med Public Health 23 suppl 2 (1992) 22-24
6. Eldor A., and Rachmilewitz E.A. The hypercoagulable state in thalassemia. Blood 99 (2002) 36-43
7. Borenstain-Ben Yashar V., Barenholz Y., Hy-Am E., Rachmilewitz E.A., and Eldor A. Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol 44 1 (1993) 63-65
8. Eldor A., Durst R., Hy-Am E., Goldfarb A., Gillis S., Rachmilewitz E.A., et al. A chronic hypercoagulable state in patients with beta-thalassemia major is already present in childhood. Br J Haematol 107 4 (1999) 739-746
9. Srinivasan P.T., and Basu J. Altered membrane phospholipid organization and erythrophagocytosis in E beta-thalassemia. Biochim Biophys Acta 1285 1 (1996) 65-70
10. Eldor A., Maclouf J., Lellouche F., Ben-Yashar V., Barenholz Y., Durst R., et al. A chronic hypercoagulable state and life-long platelet activation in beta thalassemia major. Southeast Asian J Trop Med Public Health 24 Suppl 1 (1993) 92-95
11. Cappellini M.D., Robbiolo L., Bottasso B.M., Coppola R., Fiorelli G., and Mannucci A.P. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassemia intermedia. Br J Haematol 111 2 (2000) 467-473
12. Cappellini M.D., Grespi E., Cassinerio E., Bignamini D., and Fiorelli G. Coagulation and splenectomy: an overview. Ann N Y Acad Sci 1054 (2005) 317-324
13. Shirahata A., Funaha Y., Opartkiattikul N., Fucharoen S., Laosombat V., and Yamada K. Protein C and protein S deficiency in thalassemic patients. Southeast Asian J Trop Med Public Health 23 Suppl 2 (1992) 65-73
14. Chuansamrit A., Hathirat P., Isarangkura P., Pintadit P., and Mahaphan W. Thrombotic risk of children with thalassemia. J Med Assoc Thai 76 suppl 2 (1993) 80-84
15. Michaeli J., Mittelman M., Grisaru D., and Rachmilewitz E.A. Thromboembolic complications in beta thalassemia major. Acta Haematol 87 1-2 (1992) 71-74
16. Skarsgard E., jaksic T., Wesson D., Shanding B., Ein S., Babyn P., et al. Thrombosis of the portal venous system after splenectomy for pediatric hematologic disease. J Pediatr Surg 28 9 (1993) 1109-1112
17. Opartkiattikul N., Tatsumi N., Funahara Y., Shirahara A., Wongtiraporn W., Tientadakul P., et al. Hemostatic alterations in beta-thalassemia/hemoglobin E patients. Southeast Asian J Trop Med Public Health 30 Suppl 3 (1999) 86-89
18. Ho P.J., Hall G.W., Luo L.Y., Weatheral D.J., and Thein S.L. Beta-thalassemia intermedia: is it possible consistently to predict phenotype from genotype?. Br J Haematol 100 1 (1998) 70-78
19. Pearson H.A., Cohen A.R., Giardina P.J., and Kazazian H.H. The changing profile of homozygous beta-thalassemia: demography, ethnicity, and age distribution of current North American patients and changes in two decades. Pediatrics 97 3 (1996) 352-356
20. Camaschella C., and Cappellini M.D. Thalassemia intermedia. Haematologica 80 1 (1995) 58-68
21. Lee A.Y.Y., and Ginsberg J.S. Laboratory diagnosis of venous thromboembolism. Baillieres Clin Haematol 11 (1998) 587-604
22. Wang W., Beffa M.B., Baizar L., Walker J.B., and Nesheim M.E. A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activatable fibrinolysis inhibitor. J Biol Chem 273 (1998) 27167-27181
23. Kasemsant S., and Wilairat P. Effect of vitamin E on red blood cell procoagulant activity in beta-thalassemia/Hb E disease. In: Packer L., Traber M.G., and Xin W. (Eds). Proceedings of the international symposium on natural antioxidants: molecular mechanisms and health effects (1996), AOCS Press, USA 162-166